Civic Intelligence

Destroy Duchenne

990EZ • Fiscal year 2020 • EIN 82-3268952

Jan 01, 2020 to Dec 31, 2020 • Filed on Jul 19, 2021

3182 Vandermolen DrNorco, CA 92860

(951) 444-8147

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

Score unavailable

No value available

Liabilities-to-assets requires both liabilities and assets on this filing.

Source year 2020

Liabilities / Revenue

Score unavailable

No value available

Liabilities-to-revenue requires both liabilities and revenue on this filing.

Source year 2020

Net Margin

91st percentile

57%

Higher net margin than 91% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Source year 2020

Top Officer Pay

76th percentile

$0

Higher top officer pay than 76% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2020 filings • 501(c)3 • <$500k nonprofits • Source year 2020

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2020

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2020

Assets

$52,610

No earlier filing loaded for comparison.

Net Assets

$52,610

No earlier filing loaded for comparison.

Liabilities

-

No earlier filing loaded for comparison.

Revenue

$63,948

No earlier filing loaded for comparison.

Expenses

$27,788

No earlier filing loaded for comparison.

Net Income

$36,160

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$60K$40K$20K$0Assets 2020: $52,610Net Assets 2020: $52,6102020Assets 2021: $11,116Net Assets 2021: $11,1162021

Highlighted filing

2020

Assets$52,610
Liabilities-
Net Assets$52,610

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$100K$50K$0-$50KRevenue 2020: $63,948Expenses 2020: $27,788Net Income 2020: $36,1602020Revenue 2021: $21,520Expenses 2021: $62,995Net Income 2021: -$41,4752021

Highlighted filing

2020

Revenue$63,948
Expenses$27,788
Net Income$36,160
Jump To
Filing Snapshot
Filing Period
Jan 1, 2020 to Dec 31, 2020
Signed
Jul 19, 2021
Return Version
2020v4.0
Gross Receipts
$63,948
Mission and Program Overview

Mission

Destroy duchennes mission is to complete the cure for duchenne muscular dystrophy by advancing gene-editing and gene therapy technologies, the future of medicine, into human practice.

Program Services

DescriptionGrantsExpenses
OUR FOUNDER, ELIJAH STACY WHO IS 19 YEARS OLD, HAS TAKEN AN ENTIRE YEAR TO WRITE A 100K WORD AUTOBIOGRAPHY ABOUT HIS LIFE LIVING WITH DUCHENNE AND SOME OF THE LIFE LESSONS HE HAS LEARNED BECAUSE OF IT. THIS BOOK GIVES AN HONEST AND EVEN VULNERABLE LOOK INTO WHAT LIFE IS REALLY LIKE LIVING WITH DUCHENNE MUSCULAR DYSTROPHY. BY PROPERLY LAUNCHING AND PUBLICIZING THE BOOK/ELIJAH'S STORY, WE BELIEVE WE CAN SOLVE THE AWARENESS PROBLEM SURROUNDING DUCHENNE MUSCULAR DYSTROPHY. WE BELIEVE THIS WILL LEAD TO MORE DRUGS BEING PASSED BY THE FDA BECAUSE OF A DEEPER PERSONAL UNDERSTANDING OF DUCHENNE AND WE BELIEVE IT WILL ALLOW US TO RAISE MORE FUNDS TO ACCOMPLISH OUR MISSION: COMPLETE THE CURETM FOR DUCHENNE MUSCULAR DYSTROPHY BY ADVANCING GENE-EDITING AND GENE THERAPY TECHNOLOGIES, THE FUTURE OF MEDICINE, INTO HUMAN PRACTICE.-$22,750
WITH THE DEVELOPMENT AND RISE OF GENE EDITING, CRISPR-CAS9, TECHNOLOGIES, HUMANITY HAS A REAL OPPORTUNITY TO CURE VIRTUALLY ALL GENETIC DISEASES, SUCH AS DUCHENNE MUSCULAR DYSTROPHY. GENE EDITING TECHNOLOGY HAS GIVEN US THE ABILITY TO REWRITE OUR DNA AND CORRECT FAULTY DNA, LIKE MUTATIONS THAT CAUSE DISEASES. THE APPLICATIONS FOR GENE EDITING TO IMPROVE THE WORLD ARE NEARLY ENDLESS AND WE WANT TO BE THE CHAMPION OF ADVANCING GENE EDITING TO HUMAN TRIALS FOR PEOPLE WITH DUCHENNE. IT COULD BE SAID THAT THE CURRENT STATE OF GENE EDITING TECHNOLOGY, CRISPR-CAS9, IS THE TOOL TO CURE DUCHENNE THAT NEEDS TO BE PERFECTED BEFORE IT CAN BE APPLIED IN HUMANS. MORE SCIENTIFIC STUDIES NEED TO BE DONE TO PERFECT THIS TOOL, CRISPR-CAS9, AND THAT IS WHY WE SO PASSIONATELY SAY WE NEED TO: COMPLETE THE CURE.-$4,374
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
LINDA WHITEPresident-$0--
JOSHUA SPIEGELVice Preside-$0--
DAN LANGTreasurer-$0--
VICKI SUTHERLANDSecretary-$0--
ADRIANA MAGALLANESDirector-$0--
MIGUEL ESTRADADirector-$0--
Filing and Contact Details

Filer

Filer Name
Destroy Duchenne
EIN
82-3268952
Phone
9514448147
Address
3182 VANDERMOLEN DR, NORCO, CA 92860

Signing Officer

Name
Dan Lang
Title
Treasurer
Phone
9514448147
Signed
2021-07-19
Discuss with paid preparer
Yes

Preparer

Firm
Sackett Financial Group
Address
915 W IMPERIAL HWY STE 160, BREA, CA 92821
Preparer
Braid Deweese CPA
Phone
7146719330
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 16

Expenses advertising 230 promotional merchandise 1,233 bank fees 12 merchant fees 27 computer expense 991 website 596 equipment expense 1,324 licenses fee 625 total 5,038

Form 990-ez, Part III

Destroy duchennes mission is to complete the cure for duchenne muscular dystrophy by advancing gene-editing and gene therapy technologies, the future of medicine, into human practice.

Form 990-ez, Part III, Line 28

With the development and rise of gene editing, crispr-cas9, technologies, humanity has a real opportunity to cure virtually all genetic diseases, such as duchenne muscular dystrophy. Gene editing technology has given us the ability to rewrite our dna and correct faulty dna, like mutations that cause diseases. The applications for gene editing to improve the world are nearly endless and we want to be the champion of advancing gene editing to human trials for people with duchenne. It could be said that the current state of gene editing technology, crispr-cas9, is the tool to cure duchenne that needs to be perfected before it can be applied in humans. More scientific studies need to be done to perfect this tool, crispr-cas9, and that is why we so passionately say we need to: complete the cure.

Form 990-ez, Part III, Line 29

Our founder, elijah stacy who is 19 years old, has taken an entire year to write a 100k word autobiography about his life living with duchenne and some of the life lessons he has learned because of it. This book gives an honest and even vulnerable look into what life is really like living with duchenne muscular dystrophy. By properly launching and publicizing the book/elijah's story, we believe we can solve the awareness problem surrounding duchenne muscular dystrophy. We believe this will lead to more drugs being passed by the fda because of a deeper personal understanding of duchenne and we believe it will allow us to raise more funds to accomplish our mission: complete the curetm for duchenne muscular dystrophy by advancing gene-editing and gene therapy technologies, the future of medicine, into human practice.

Raw XML Appendix141 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
CompensationExplanation/CompensationExplanationGrp/PersonNm0LINDA WHITE
CompensationExplanation/CompensationExplanationGrp/PersonNm1JOSHUA SPIEGEL
CompensationExplanation/CompensationExplanationGrp/PersonNm2DAN LANG
CompensationExplanation/CompensationExplanationGrp/PersonNm3VICKI SUTHERLAND
CompensationExplanation/CompensationExplanationGrp/PersonNm4ADRIANA MAGALLANES
CompensationExplanation/CompensationExplanationGrp/PersonNm5MIGUEL ESTRADA
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/PersonNm0SACKETT FINANCIAL GROUP
IRS990EZ/BooksInCareOfDetail/PhoneNum07146719330
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt0915 W IMPERIAL HIGHWAY 160
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0BREA
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd092821
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt016450
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt052610
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt063948
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt036160
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt016450
IRS990EZ/Form990TotalAssetsGrp/EOYAmt052610
IRS990EZ/GrossReceiptsAmt063948
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingAccrualInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt016450
IRS990EZ/NetAssetsOrFundBalancesEOYAmt052610
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt016450
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt052610
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt01.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt11.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt21.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt31.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt41.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt51.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0LINDA WHITE
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1JOSHUA SPIEGEL
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2DAN LANG
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3VICKI SUTHERLAND
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4ADRIANA MAGALLANES
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm5MIGUEL ESTRADA
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0PRESIDENT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1VICE PRESIDE
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2TREASURER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3SECRETARY
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt5DIRECTOR
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherExpensesTotalAmt05038
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0DESTROY DUCHENNES MISSION IS TO COMPLETE THE CURE FOR DUCHENNE MUSCULAR DYSTROPHY BY ADVANCING GENE-EDITING AND GENE THERAPY TECHNOLOGIES, THE FUTURE OF MEDICINE, INTO HUMAN PRACTICE.
IRS990EZ/PrintingPublicationsPostageAmt022750
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0WITH THE DEVELOPMENT AND RISE OF GENE EDITING, CRISPR-CAS9, TECHNOLOGIES, HUMANITY HAS A REAL OPPORTUNITY TO CURE VIRTUALLY ALL GENETIC DISEASES, SUCH AS DUCHENNE MUSCULAR DYSTROPHY. GENE EDITING TECHNOLOGY HAS GIVEN US THE ABILITY TO REWRITE OUR DNA AND CORRECT FAULTY DNA, LIKE MUTATIONS THAT CAUSE DISEASES. THE APPLICATIONS FOR GENE EDITING TO IMPROVE THE WORLD ARE NEARLY ENDLESS AND WE WANT TO BE THE CHAMPION OF ADVANCING GENE EDITING TO HUMAN TRIALS FOR PEOPLE WITH DUCHENNE. IT COULD BE SAID THAT THE CURRENT STATE OF GENE EDITING TECHNOLOGY, CRISPR-CAS9, IS THE TOOL TO CURE DUCHENNE THAT NEEDS TO BE PERFECTED BEFORE IT CAN BE APPLIED IN HUMANS. MORE SCIENTIFIC STUDIES NEED TO BE DONE TO PERFECT THIS TOOL, CRISPR-CAS9, AND THAT IS WHY WE SO PASSIONATELY SAY WE NEED TO: COMPLETE THE CURE.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt1OUR FOUNDER, ELIJAH STACY WHO IS 19 YEARS OLD, HAS TAKEN AN ENTIRE YEAR TO WRITE A 100K WORD AUTOBIOGRAPHY ABOUT HIS LIFE LIVING WITH DUCHENNE AND SOME OF THE LIFE LESSONS HE HAS LEARNED BECAUSE OF IT. THIS BOOK GIVES AN HONEST AND EVEN VULNERABLE LOOK INTO WHAT LIFE IS REALLY LIKE LIVING WITH DUCHENNE MUSCULAR DYSTROPHY. BY PROPERLY LAUNCHING AND PUBLICIZING THE BOOK/ELIJAH'S STORY, WE BELIEVE WE CAN SOLVE THE AWARENESS PROBLEM SURROUNDING DUCHENNE MUSCULAR DYSTROPHY. WE BELIEVE THIS WILL LEAD TO MORE DRUGS BEING PASSED BY THE FDA BECAUSE OF A DEEPER PERSONAL UNDERSTANDING OF DUCHENNE AND WE BELIEVE IT WILL ALLOW US TO RAISE MORE FUNDS TO ACCOMPLISH OUR MISSION: COMPLETE THE CURETM FOR DUCHENNE MUSCULAR DYSTROPHY BY ADVANCING GENE-EDITING AND GENE THERAPY TECHNOLOGIES, THE FUTURE OF MEDICINE, INTO HUMAN PRACTICE.
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt04374
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt122750
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt027788
IRS990EZ/TotalProgramServiceExpensesAmt027124
IRS990EZ/TotalRevenueAmt063948
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0WWW.DESTROYDUCHENNE.ORG
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt063948
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt063948
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct01.00000
IRS990ScheduleA/PublicSupportTotal170Amt063948
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt063948
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt063948
IRS990ScheduleA/TotalSupportAmt063948
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0EXPENSES ADVERTISING 230 PROMOTIONAL MERCHANDISE 1,233 BANK FEES 12 MERCHANT FEES 27 COMPUTER EXPENSE 991 WEBSITE 596 EQUIPMENT EXPENSE 1,324 LICENSES FEE 625 TOTAL 5,038
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1DESTROY DUCHENNES MISSION IS TO COMPLETE THE CURE FOR DUCHENNE MUSCULAR DYSTROPHY BY ADVANCING GENE-EDITING AND GENE THERAPY TECHNOLOGIES, THE FUTURE OF MEDICINE, INTO HUMAN PRACTICE.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2WITH THE DEVELOPMENT AND RISE OF GENE EDITING, CRISPR-CAS9, TECHNOLOGIES, HUMANITY HAS A REAL OPPORTUNITY TO CURE VIRTUALLY ALL GENETIC DISEASES, SUCH AS DUCHENNE MUSCULAR DYSTROPHY. GENE EDITING TECHNOLOGY HAS GIVEN US THE ABILITY TO REWRITE OUR DNA AND CORRECT FAULTY DNA, LIKE MUTATIONS THAT CAUSE DISEASES. THE APPLICATIONS FOR GENE EDITING TO IMPROVE THE WORLD ARE NEARLY ENDLESS AND WE WANT TO BE THE CHAMPION OF ADVANCING GENE EDITING TO HUMAN TRIALS FOR PEOPLE WITH DUCHENNE. IT COULD BE SAID THAT THE CURRENT STATE OF GENE EDITING TECHNOLOGY, CRISPR-CAS9, IS THE TOOL TO CURE DUCHENNE THAT NEEDS TO BE PERFECTED BEFORE IT CAN BE APPLIED IN HUMANS. MORE SCIENTIFIC STUDIES NEED TO BE DONE TO PERFECT THIS TOOL, CRISPR-CAS9, AND THAT IS WHY WE SO PASSIONATELY SAY WE NEED TO: COMPLETE THE CURE.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3OUR FOUNDER, ELIJAH STACY WHO IS 19 YEARS OLD, HAS TAKEN AN ENTIRE YEAR TO WRITE A 100K WORD AUTOBIOGRAPHY ABOUT HIS LIFE LIVING WITH DUCHENNE AND SOME OF THE LIFE LESSONS HE HAS LEARNED BECAUSE OF IT. THIS BOOK GIVES AN HONEST AND EVEN VULNERABLE LOOK INTO WHAT LIFE IS REALLY LIKE LIVING WITH DUCHENNE MUSCULAR DYSTROPHY. BY PROPERLY LAUNCHING AND PUBLICIZING THE BOOK/ELIJAH'S STORY, WE BELIEVE WE CAN SOLVE THE AWARENESS PROBLEM SURROUNDING DUCHENNE MUSCULAR DYSTROPHY. WE BELIEVE THIS WILL LEAD TO MORE DRUGS BEING PASSED BY THE FDA BECAUSE OF A DEEPER PERSONAL UNDERSTANDING OF DUCHENNE AND WE BELIEVE IT WILL ALLOW US TO RAISE MORE FUNDS TO ACCOMPLISH OUR MISSION: COMPLETE THE CURETM FOR DUCHENNE MUSCULAR DYSTROPHY BY ADVANCING GENE-EDITING AND GENE THERAPY TECHNOLOGIES, THE FUTURE OF MEDICINE, INTO HUMAN PRACTICE.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 16
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART III
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990-EZ, PART III, LINE 28
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990-EZ, PART III, LINE 29
ReturnHeader/BuildTS02022-09-23 18:48:47Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0DAN LANG
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0TREASURER
ReturnHeader/BusinessOfficerGrp/PhoneNum09514448147
ReturnHeader/BusinessOfficerGrp/SignatureDt02021-07-19
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0DESTROY DUCHENNE
ReturnHeader/Filer/BusinessNameControlTxt0DEST
ReturnHeader/Filer/EIN0823268952
ReturnHeader/Filer/PhoneNum09514448147
ReturnHeader/Filer/USAddress/AddressLine1Txt03182 VANDERMOLEN DR
ReturnHeader/Filer/USAddress/CityNm0NORCO
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd092860
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0330946321
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0SACKETT FINANCIAL GROUP
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0915 W IMPERIAL HWY STE 160
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0BREA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd092821
ReturnHeader/PreparerPersonGrp/PhoneNum07146719330
ReturnHeader/PreparerPersonGrp/PreparationDt02021-07-19
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0BRAID DEWEESE CPA
ReturnHeader/ReturnTs02021-07-22T14:52:48-05:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm0DAN
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm0LANG
ReturnHeader/TaxPeriodBeginDt02020-01-01
ReturnHeader/TaxPeriodEndDt02020-12-31
ReturnHeader/TaxYr02020

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings